Who are Rotavirus vaccine's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Rotavirus Vaccine, Live, Pentavalent, Mumps vaccine, Live (MV), BCG solvent, MMR vaccine (Priorix), Mumps vaccine, RotaTeq.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/rotavirus-vaccine.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Rotavirus vaccine — Competitive Intelligence Brief

Rotavirus vaccine (Rotavirus vaccine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Live attenuated vaccine. Area: Immunology / Infectious Disease.

marketed Live attenuated vaccine Immunology / Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

Rotavirus vaccine (Rotavirus vaccine) — PATH. Rotavirus vaccine stimulates the immune system to produce antibodies and cellular immunity against rotavirus, preventing infection and severe gastroenteritis.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Rotavirus vaccine TARGET	Rotavirus vaccine	PATH	marketed	Live attenuated vaccine
Rotavirus Vaccine, Live, Pentavalent	Rotavirus Vaccine, Live, Pentavalent	Sanofi Pasteur, a Sanofi Company	marketed	Live attenuated vaccine
Mumps vaccine, Live (MV)	Mumps vaccine, Live (MV)	Sinovac Biotech Co., Ltd	marketed	Live attenuated vaccine
BCG solvent	BCG solvent	Bandim Health Project	marketed	Live attenuated vaccine
MMR vaccine (Priorix)	MMR vaccine (Priorix)	GlaxoSmithKline	marketed	Live attenuated vaccine
Mumps vaccine	Mumps vaccine	Sinovac (Dalian) Vaccine Technology Co., Ltd.	marketed	Live attenuated vaccine	Mumps virus surface antigens
RotaTeq	RotaTeq	National Institute of Pediatrics, Mexico	marketed	Live attenuated vaccine	Rotavirus VP4 and VP7 surface proteins

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Live attenuated vaccine class)

GlaxoSmithKline · 19 drugs in this class
Merck Sharp & Dohme LLC · 11 drugs in this class
Sanofi Pasteur, a Sanofi Company · 9 drugs in this class
PATH · 5 drugs in this class
Sanofi · 5 drugs in this class
Bandim Health Project · 5 drugs in this class
Centers for Disease Control and Prevention · 3 drugs in this class
International Centre for Diarrhoeal Disease Research, Bangladesh · 3 drugs in this class
Beijing Center for Disease Control and Prevention · 2 drugs in this class
Aga Khan University · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Rotavirus vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/rotavirus-vaccine. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab